Header Logo

Connection

Kelly Standifer to Receptors, Opioid, delta

This is a "connection" page, showing publications Kelly Standifer has written about Receptors, Opioid, delta.
Connection Strength

0.455
  1. Antisense oligodeoxynucleotides to the cloned delta receptor DOR-1: uptake, stability, and regulation of gene expression. J Neurochem. 1995 Nov; 65(5):1981-7.
    View in: PubMed
    Score: 0.129
  2. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells. J Pharmacol Exp Ther. 1994 Sep; 270(3):1246-55.
    View in: PubMed
    Score: 0.119
  3. Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor. Neuron. 1994 Apr; 12(4):805-10.
    View in: PubMed
    Score: 0.116
  4. Reduction of neurotransmitter receptor and G-protein expression in vivo and in vitro by antisense oligodeoxynucleotide treatment. Methods Enzymol. 2000; 314:90-103.
    View in: PubMed
    Score: 0.043
  5. TIPP[psi], a highly selective delta ligand. Neurosci Lett. 1994 Nov 07; 181(1-2):47-9.
    View in: PubMed
    Score: 0.030
  6. Gender effects and central opioid analgesia. Pain. 1991 Apr; 45(1):87-94.
    View in: PubMed
    Score: 0.006
  7. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 1990 Dec 03; 535(1):101-9.
    View in: PubMed
    Score: 0.006
  8. Modulation of mu 1, mu 2, and delta opioid binding by divalent cations. Biochem Pharmacol. 1990 Jul 15; 40(2):382-4.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.